Evidence map›Paper›PMID 41570269›Full record

ArticleNeurology2026

Iron-Rim Lesions in the Optic Chiasm in Multiple Sclerosis: A Neuropathologic Case Series.

Andrew Lockhart, Marco Pisa, Hal Drakesmith, Gabriele C DeLuca

Abstract readCase Reports
In one paragraph

Article in Neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andrew LockhartNuffield Department of Clinical Neurosciences, University of Oxford; United Kingdom; and.
Marco PisaNuffield Department of Clinical Neurosciences, University of Oxford; United Kingdom; and.ORCID 0000-0001-9409-6864
Hal DrakesmithMRC Weatherall Institute of Molecular Medicine, University of Oxford, United Kingdom.
Gabriele C DeLucaNuffield Department of Clinical Neurosciences, University of Oxford; United Kingdom; and.ORCID 0000-0003-0342-5197

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of this study was to demonstrate the presence of iron-rim lesions (IRLs) in the anterior visual pathway in multiple sclerosis (MS).

methodsPostmortem formalin-fixed paraffin-embedded anterior visual pathway tissues (optic chiasms) from 3 donors with MS were examined for iron using Turnbull Blue histochemistry. Demyelinated lesions were identified and staged with immunohistochemistry for myelin proteolipid protein and CD68.

resultsA total of 9 lesions were identified, all of which were mixed active/inactive. Iron-positive microglia and macrophages were identified at the inflammatory borders in all 3 cases, in 8 of the 9 lesions. Within the inactive core, iron-positive astrocytes and, rarely axons, could be seen. Iron-positive macrophages were also seen in nonlesional white matter. DISCUSSION: IRLs are common in mixed active/inactive MS lesions in the anterior visual pathway. IRLs are the pathologic correlate of paramagnetic rim lesions (PRLs) on MRI, the number of which in the brain correlates with the extent of disability. PRLs have, heretofore, not been described in the anterior visual pathway. Future work aimed at overcoming the challenges in detecting these lesions in the anterior visual pathway is warranted, to ensure that extent of chronic inflammation is not underestimated.

Indexed as

IronMultiple SclerosisOptic ChiasmAdultAgedAntigens, Differentiation, MyelomonocyticFemaleHumansMacrophagesMagnetic Resonance ImagingMaleMicrogliaMiddle AgedVisual PathwaysWhite MatterAntigens, Differentiation, MyelomonocyticIron

Identifiers

PMID41570269
PMCPMC12833750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.